Alemtuzumab

Alemtuzumab is a humanized monoclonal antibody directed against CD52. Alemtuzumab is being used in the treatment of CD52 expressing tumours and relapsing remitting form of multiple sclerosis.

What can Sanquin do for you?

• Measure drug levels of free drug in the serum using an validated ELISA.
• Measure the immunogenicity of alemtuzumab.
• Provide assay reagents or co-develop novel testing strategies.
• Folllowing ISO, FDA/EMA, RUO guidelines.

Enquiry

Enquire about our drug level and ADA assays by emailing us at [email protected].